Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2005
06/23/2005CA2549291A1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
06/23/2005CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2549195A1 Bioadhesive polymers with catechol functionality
06/23/2005CA2549161A1 Prevention and/or reduction of photoreceptor degeneration with retinoids
06/23/2005CA2549160A1 Treatment and preventions of asthma
06/23/2005CA2548922A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders
06/23/2005CA2548918A1 Alpha-amino acid derivatives and use thereof as medicines
06/23/2005CA2548892A1 Compositions for treatment of ear disorders and methods of use thereof
06/23/2005CA2548822A1 Mucoadhesive drug delivery devices and methods of making and using thereof
06/23/2005CA2548742A1 Dpp-iv inhibitors
06/23/2005CA2548605A1 Chp-gemcitabin combined agent and use thereof as anti-tumoural active substances
06/23/2005CA2548602A1 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
06/23/2005CA2548600A1 Cathepsin cysteine protease inhibitors
06/23/2005CA2548559A1 Intranasal compositions comprising granisetron and chitosan
06/23/2005CA2548491A1 Synergistic anti-cancer compositions
06/23/2005CA2548487A1 Methods and compositions for slowing aging
06/23/2005CA2548447A1 Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia
06/23/2005CA2548443A1 Use of chp as an inhibitor of glutathione s-transferases and collagen iv
06/23/2005CA2548427A1 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
06/23/2005CA2548426A1 Substituted piperazines
06/23/2005CA2548308A1 Phosphatase inhibitor sample collection system
06/23/2005CA2548281A1 Method of preparation of mixed phase co-crystals with active agents
06/23/2005CA2548276A1 Keto lactam compounds and use thereof
06/23/2005CA2548250A1 Practical, cost-effective synthesis of ubiquinones
06/23/2005CA2548172A1 Quinoxalines useful as inhibitors of protein kinases
06/23/2005CA2548150A1 Polynucleotides for reducing respiratory syncytial virus gene expression
06/23/2005CA2548144A1 Dosing methods for .beta.-d-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
06/23/2005CA2548140A1 Oligosaccharide compositions and use thereof in the treatment of infection
06/23/2005CA2548038A1 Treatment of inflammatory disorders of the epithelium with low dose 2,3-benzodiazepines
06/23/2005CA2548011A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds as ikk inhibitors
06/23/2005CA2548009A1 Naphthyridine derivatives and their use as modulators of muscarinic receptors
06/23/2005CA2547911A1 Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake
06/23/2005CA2547863A1 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
06/23/2005CA2547815A1 Silver coatings and methods of manufacture
06/23/2005CA2547579A1 Secosterols derived from corals useful as neuroactive substances
06/23/2005CA2547573A1 N-alkyl pyrroles as hmg-coa reductase inhibitors
06/23/2005CA2547570A1 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione for induction of fetal hemoglobin in individuals having anemia
06/23/2005CA2547410A1 1,2,3-triazole amide derivatives as inhibitors of cytokie production
06/23/2005CA2547404A1 Compositions comprising an hiv protease inhibitor
06/23/2005CA2547391A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
06/23/2005CA2547072A1 Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
06/23/2005CA2546920A1 Methods for suppressing an immune response or treating a proliferative disorder
06/23/2005CA2546895A1 Oxazole derivatives of tetracyclines
06/23/2005CA2546496A1 Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality
06/23/2005CA2546053A1 Amelioration of cataracts, macular degeneration and other ophthalmic diseases
06/23/2005CA2545457A1 11-o-methylgeldanamycin compounds
06/23/2005CA2545112A1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
06/23/2005CA2544018A1 Compositions and methods to reduce mutagenesis
06/23/2005CA2539003A1 Compositions and methods for topical treatment of skin infection
06/23/2005CA2490218A1 Extracorporeal photopheresis in combination with anti-tnf treatment
06/22/2005EP1544295A1 Salt-inducible kinases 2 and use thereof
06/22/2005EP1544281A1 Fat composition
06/22/2005EP1544213A1 Use of ligands of the antigen cd52 for the treatment of solid tumours and bone-related cancerous diseases
06/22/2005EP1544207A1 Process for producing glycoside
06/22/2005EP1544201A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
06/22/2005EP1544199A1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor
06/22/2005EP1544198A1 A process for the preparation of crystalline losartan potassium
06/22/2005EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
06/22/2005EP1543841A1 Soild nano pharmaceutical formulation and preparation method thereof
06/22/2005EP1543833A1 Phosphorylated dextran
06/22/2005EP1543832A2 Use of trans-4[4-(3-chloro-4-methoxy-benzylamino) benzothieno[2,3-d]pyrimidin-2-yl]-cyclohexanecarboxylic acid in the treatment of extrapyramidal movement disorders
06/22/2005EP1543831A1 Pregabalin composition
06/22/2005EP1543830A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
06/22/2005EP1543829A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
06/22/2005EP1543827A1 Emulsion of perfluororganic compounds exhibiting gas-transport properties, a surface-active agent for said emulsion and method for the production thereof
06/22/2005EP1543826A1 Concentrated aqueous solution of ambroxol
06/22/2005EP1543824A2 Thiazole derivatives to counter advanced glycation
06/22/2005EP1543821A1 External preparation
06/22/2005EP1543735A1 Nutritional composition for wound healing
06/22/2005EP1543159A2 Antisense modulation of endothelial specific molecule 1 expression
06/22/2005EP1543158A1 Regulated aptamer therapeutics
06/22/2005EP1543148A1 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
06/22/2005EP1543145A2 Antifungal therapeutic targets
06/22/2005EP1543119A2 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
06/22/2005EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents
06/22/2005EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
06/22/2005EP1543023A2 Secondary binding site of dipeptidyl peptidase iv (dp iv)
06/22/2005EP1543010A1 N-substituted hydromorphones and the use thereof
06/22/2005EP1543009A1 Pyrrolotriazine kinase inhibitors
06/22/2005EP1543003A2 Imidazo[1,2-a]pyridines
06/22/2005EP1543002A1 Preparation of 1h-imidazo 4,5-c]quinolin-4-amines via1h-imidazo 4,5-c]quinolin-4-phthalimide intermediates
06/22/2005EP1543001A1 Novel pyrazolopyridine derivatives as pharmaceutical agents
06/22/2005EP1542999A1 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
06/22/2005EP1542997A2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
06/22/2005EP1542996A2 Octahydro-2-h-naphtho 1,2-f indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
06/22/2005EP1542995A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors
06/22/2005EP1542993A1 Piperazine derivatives and methods of use
06/22/2005EP1542990A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors
06/22/2005EP1542987A1 Piperidine-n-oxide-derivatives
06/22/2005EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor
06/22/2005EP1542978A1 Novel bio-active molecules
06/22/2005EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
06/22/2005EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
06/22/2005EP1542971A1 4-pyrrolidino-phenyl-benzyl ether derivatives
06/22/2005EP1542970A1 Pyrrolidone derivatives as maob inhibitors
06/22/2005EP1542969A1 Pyrrolidone derivatives as maob inhibitors
06/22/2005EP1542966A1 Aromatic liver x-receptor modulators
06/22/2005EP1542961A1 Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
06/22/2005EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids
1 ... 4643 4644 4645 4646 4647 4648 4649 4650 4651 4652 4653 4654 4655 4656 4657 4658 4659 4660 4661 4662 4663 ... 7860